Richmond Pharmacology is a recognised thought leader and regular contributor at scientific meetings worldwide. Explore our upcoming and past events below.
Richmond Pharmacology will attend AHA Scientific Sessions 2025 in New Orleans, with CEO Dr Jörg Täubel and CSO James Rickard. They will discuss early-phase cardiovascular research, digital endpoints, regulatory engagement, and patient-first strategies.
Richmond Pharmacology will attend AHA Scientific Sessions 2025 in New Orleans, with CEO Dr Jörg Täubel and CSO James Rickard. They will discuss early-phase cardiovascular research, digital endpoints, regulatory engagement, and patient-first strategies.
13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.